IP Library › Assignment 062318/0868
Patent Assignment
Reel/Frame 062318/0868

Assignment of Assignor's Interest

Recorded: 2023-01-09 Pages: 9
Assignor
VIRGINIA COMMONWEALTH UNIVERSITY
Executed: 2021-10-12
Assignees
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
810 VERMONT AVENUE, N.W., OFFICE OF GENERAL COUNSEL, WASHINGTON, DISTRICT OF COLUMBIA, 20420
VIRGINIA COMMONWEALTH UNIVERSITY
800 EAST LEIGH STREET, SUITE 3000, RICHMOND, VIRGINIA, 23298
Covered Properties (4)
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Application: 15/106,883 →
Publication: US 2017/0014429
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Application: 16/368,553 →
Publication: US 2019/0350945
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Application: 16/983,492 →
Publication: US 2021/0046091
Use of Oxysterol Sulfates 5-Cholesten-3,25-Diol,3-Sulfate (25HC3S) and 5- Cholesten 3,25- Diol, Disulfate (25HCDS) to Treat Necrosis, Apoptosis, Acute Liver Failure, and/or Kidney Failure
Application: 61/920,617 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 17, 2014
From: REN, SHUNLIN
To: VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 034529/0879 →
Assignment of Assignor's Interest Jun 21, 2016
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 038971/0172 →
Assignment of Assignor's Interest Jul 30, 2019
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 049906/0155 →
Assignment of Assignor's Interest Mar 17, 2021
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 055626/0551 →
Merger Feb 19, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073837/0231 →
Merger Feb 25, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073889/0196 →
Security Interest Mar 30, 2026
From: BAUSCH HEALTH IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 074223/0753 →
Security Interest Mar 30, 2026
From: MEDICIS PHARMACEUTICAL CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 074227/0509 →